AbbVie confirms Shire withdrawal as Allergan hovers

Allergan has emerged as a potential bidder for Shire after AbbVie officially confirmed it has abandoned its US$55bn bid for the UK speciality pharmaceutical company. Allergan shareholder Paulson & Co…